By Deena Beasley

(Reuters) -Retail pharmacies and prescription drug savings site GoodRx are talking with the Trump administration about joining its TrumpRx website, they told Reuters, suggesting an expansion beyond the early description of it as a link to pharmaceutical companies’ direct discounts.

Drugmakers, including Pfizer and Amgen, are offering to sell some brand-name medications directly to consumers at the negotiated prices they get from insurers rather than much higher list prices.

Some say they will work with TrumpRx, spurred in part by President Donald Trump’s threats of steep tariffs on drugmakers that don’t cut prices and increase U.S. manufacturing. The site is due to launch next year.

At a White House event last week, Trump and health officials described TrumpRx as a way

See Full Page